ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

OBD Oxford Biodynamics Plc

8.13
0.09 (1.12%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Oxford Biodynamics Plc LSE:OBD London Ordinary Share GB00BD5H8572 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.09 1.12% 8.13 8.10 8.16 8.10 8.10 8.10 80,528 16:35:01
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 1.34M -10.83M -0.0535 -1.51 16.27M
Oxford Biodynamics Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker OBD. The last closing price for Oxford Biodynamics was 8.04p. Over the last year, Oxford Biodynamics shares have traded in a share price range of 5.32p to 51.00p.

Oxford Biodynamics currently has 202,303,415 shares in issue. The market capitalisation of Oxford Biodynamics is £16.27 million. Oxford Biodynamics has a price to earnings ratio (PE ratio) of -1.51.

Oxford Biodynamics Share Discussion Threads

Showing 1876 to 1898 of 1975 messages
Chat Pages: 79  78  77  76  75  74  73  72  71  70  69  68  Older
DateSubjectAuthorDiscuss
13/3/2024
15:56
Well this is nice
collywobbler
06/3/2024
15:16
sp more or less back to where it started before the test rollout hype

last reported cash was £5.25m at 9/23

prelims reported Forecast cash balances in the budget, whilst positive throughout the period covered, are expected to be reduced to a low level relative to the Group's cost base through much of 2024...a "possible" scenario that reflects significantly reduced test volumes compared to the budget and a "downside" scenario with still lower test volumes and no new pharma projects assumed. Without any remedial action to reduce costs or delay expenditure, in these scenarios the Group and Company would need to obtain additional funds during the second quarter of 2024 in order to continue as a going concern.

I'd bet on a dilutive funding in the next quarter & ideally they need to bump the share price up via an rns or 2 to get it away at a decent level equivalent or above the current 11p, otherwise looking at a 5p raise

elpirata
02/3/2024
14:01
HiLtt6uiij
badger60
02/3/2024
07:54
10p anybody ?
hatfullofsky
27/2/2024
16:50
Needs news
hatfullofsky
25/2/2024
10:36
Uppompei wrote

"Is this test just a combination of a PSA result and genetic screening? I know the two are used in the process but is the method patentable/unique or could it be done by any company with the right equipment, but OBD just happen to be the first?"

Imo the answer is
Yes.

So, OBD does NOT have a test for prostate cancer, as some might think/hope.

smithie6
21/2/2024
09:26
I'm surprised it's struggling cash wise. If this is the game changer it's presented as it should be a no brainer? From a personal point of view if I could avoid a DRE, a cystoscopy, an ultrasound, a CT and a biopsy until after a straightforward blood test confirms they are necessary, I think any consultant would also agree...aside the cost of a work up like this over the current £750 this test costs (before an NHS negotiated price).I'm sure this has been discussed before so apologies but I'm just trying to get my head round what else could be in play.I should detach myself from personal experience.
uppompeii
20/2/2024
01:11
At the end of the day they need to turn it into money and a profitable business and thus far are failing to do that. Many companies struggle at this stage to turn promise into cash and when they are so. Loss making like obd it means they are required to raise capital at ever lower prices. In this market that resits in an share price that gets hammered and ehyvobd is struggling as everyone knows its coming.

Getting a deal with a large upfront payment at this stage is unlikely but a small one won't provide enough runeya to see a profit and so a rights issue is the most likely outcome at a big discount given the amount they are likely to require. Sad but true for many small companies atm

bones698
19/2/2024
07:47
Many thanks
uppompeii
18/2/2024
22:31
Over many years OBD developed an IP protected epigenetics platform. They are a world leader in this field. Sadly, although predictably, this is not reflected in how Mr Mkt currently values it - he is a brutal realist!



www.94percent.com (all the info, but won't hyperlink for some reason)

rambutan2
18/2/2024
21:13
I came across this via personal circumstances ...so apologies for this question and if it is covered way back.Is this test just a combination of a PSA result and genetic screening? I know the two are used in the process but is the method patentable/unique or could it be done by any company with the right equipment, but OBD just happen to be the first?
uppompeii
14/2/2024
15:43
Just no buyers in this market
hatfullofsky
29/1/2024
22:01
I don't think anybody is ignoring the need for additional capital, that was a known. How they get it is all speculation at the moment but you keep banging the drum. It's the uncertainty that is causing PI's to sell.
hatfullofsky
29/1/2024
17:26
If they leave it to the last minute this will tank big time m they already left it too late and look what's happening . Now be lucky to get it away for 10p . If you look back I warned about this happening and now it's in the funding spiral as everyone knows it's coming so the pressure is on the share price . Also once they go to the city whoever is providing the funds will forward sell to make their money back .
So either they have done that and that's why the price is falling or if not this could get very painful indeed once they do . Needing capital in these markets kills shareprices just look around . Ignoring the facts and burying your head in the sand won't stop what's coming

bones698
25/1/2024
14:35
money is not needed until Q2
hsdeo
25/1/2024
14:26
20p coming
timberwolf3
25/1/2024
14:21
Placing coming
jambam
25/1/2024
13:00
Nice to see a blue day
hatfullofsky
25/1/2024
12:59
Still holds 27m though
hatfullofsky
25/1/2024
09:07
also diggle wont be happy witting of millions of loss!! Need a new BOD
hsdeo
25/1/2024
09:02
Has it bottomed out??
hsdeo
24/1/2024
15:06
lucky for Diggle he managed to pump out over 1m shares at average 40p before the law of gravity took over, he knew what was coming
elpirata
23/1/2024
17:56
Chart is a sign they likely approached the market for a fund raise and once that happens they begin shifting/ forward selling the shares to recoup some of the funding costs . As I said longer they wait the lower it is likely to go now .
bones698
Chat Pages: 79  78  77  76  75  74  73  72  71  70  69  68  Older

Your Recent History

Delayed Upgrade Clock